美国SLL Sciences, Inc.

SLL Sciences is an early-stage company focused on the use and application of human embryonic stem (hES) cells. Our proprietary hES cell-based technology enables the discovery of therapeutics that direct or modulate stem cell fate.

SLL applies its proprietary hES cell technology in concert with conventional drug discovery strategies to identify new genomic targets and to develop small-molecule and biologic drugs, both internally and in collaboration with bio/pharmaceutical industry partners. Our primary therapeutic focus is cancer and, secondarily, neurodegenerative diseases.